Orphans and babies as young as three months old have been used as guinea pigs in potentially dangerous medical experiments sponsored by a giant pharmaceutical company.
British giant GlaxoSmithKline is embroiled in the scandal.
The firm sponsored experiments on the children from Incarnation Children's Center, a New York care home that specializes in treating HIV sufferers and is run by Catholic charities.
The children had either been infected with HIV or born to HIV-positive mothers.
Their parents were dead, untraceable or deemed unfit to look after them.
According to documents, Glaxo has sponsored at least four medical trials since 1995 using Hispanic and black children at Incarnation.
The documents give details of all clinical trials in the US and reveal that the experiments sponsored by Glaxo were designed to test the "safety and tolerance" of AIDS medications, some of which have potentially dangerous side effects.
Glaxo manufactures a number of drugs designed to treat HIV, including AZT.
Normally, trials on children would require parental consent but, as the infants are in care, New York's authorities hold that role.
The city health department has launched an investigation into claims that more than 100 children at Incarnation were used in 36 experiments -- at least four of them co-sponsored by Glaxo.
Some of these trials were designed to test the "toxicity" of AIDS medications.
One involved giving children as young as 4 years old a high-dosage cocktail of seven drugs at one time.
Another looked at the reaction in six-month-old babies to a double dose of measles vaccine.
Most experiments were funded by federal agencies like the National Institute of Allergy and Infectious Diseases.
Until now Glaxo's role had not emerged.
In 1997 an experiment co-sponsored by Glaxo used children from Incarnation to "obtain tolerance, safety and pharmacokinetic" data for herpes drugs.
In a more recent experiment, the children were used to test the drug AZT.
A third experiment sponsored by Glaxo and US drug firm Pfizer investigated the "long-term safety" of anti-bacterial drugs on three-month-old babies.
The medical establishment has defended the trials, arguing they enabled these children to obtain state-of-the-art therapy that they would otherwise not have received for illnesses that could potentially be fatal.
However, health campaigners argue there is a difference between providing the latest drugs and experimentation.
They claim many of the experiments were "phase 1 trials" -- among the most risky.
They also claim that HIV tests for babies are not a reliable indicator of actual infection and therefore toxic drugs could have been given to healthy infants. HIV drugs are similar to those used in chemotherapy and can have serious side effects.
Vera Sharav, president of the Alliance for Human Research Protection, said the children had been treated like "laboratory animals."
"These are some of the most vulnerable individuals in the country and there appears to be a policy of giving drug firms access to them," she said.
"Throughout the history of medical research we have seen prisoners abused, the mentally ill abused and now poor kids in a care home," she said.
Sharav has urged the US Food and Drug Administration to investigate and has demanded complete disclosure of all adverse effects suffered by the children, including deaths.
Glaxo has confirmed it provided funds for some of the experiments but denied any improper action.
A spokeswoman said, "These studies were implemented by the US AIDS Clinical Trial Group, a clinical research network paid for by the National Institutes of Health.
"Glaxo's involvement in such studies would have been to provide study drugs or funding but we would have no interactions with the patients.
"Generally speaking, clinical research is carefully regulated in the US and it would be the responsibility of the appropriate authorities to ensure all subjects in a clinical trial provided appropriate, informed consent to conform with all local laws and regulations regarding legal authority in the case of minors."
The Incarnation trials were run by Columbia University Medical Center doctors.
Columbia spokeswoman Annie Bayne said there had been no clinical trials at Incarnation since 2000 and that consent for the children was provided by the Administration for Children's Services, which relies on a panel of doctors and lawyers to determine whether the benefits of a trial for each child outweighs the risks to the child.
"There are many safeguards in the system. HIV is eventually a fatal disease, but drug therapy has lengthened life significantly," Bayne said.
A spokesman for Incarnation said regarding the scandal, "The purpose of the trials was to test the efficacy of HIV medication."
"These trials were based on scientific evidence of their potential value in the treatment of HIV- infected children," the spokesman said.
A French-Algerian man went on trial in France on Monday for burning to death his wife in 2021, a case that shocked the public and sparked heavy criticism of police for failing to take adequate measures to protect her. Mounir Boutaa, now 48, stalked his Algerian-born wife Chahinez Daoud following their separation, and even bought a van he parked outside her house near Bordeaux in southwestern France, which he used to watch her without being detected. On May 4, 2021, he attacked her in the street, shot her in both legs, poured gasoline on her and set her on fire. A neighbor hearing
DEATH CONSTANTLY LOOMING: Decades of detention took a major toll on Iwao Hakamada’s mental health, his lawyers describing him as ‘living in a world of fantasy’ A Japanese man wrongly convicted of murder who was the world’s longest-serving death row inmate has been awarded US$1.44 million in compensation, an official said yesterday. The payout represents ￥12,500 (US$83) for each day of the more than four decades that Iwao Hakamada spent in detention, most of it on death row when each day could have been his last. It is a record for compensation of this kind, Japanese media said. The former boxer, now 89, was exonerated last year of a 1966 quadruple murder after a tireless campaign by his sister and others. The case sparked scrutiny of the justice system in
DITCH TACTICS: Kenyan officers were on their way to rescue Haitian police stuck in a ditch suspected to have been deliberately dug by Haitian gang members A Kenyan policeman deployed in Haiti has gone missing after violent gangs attacked a group of officers on a rescue mission, a UN-backed multinational security mission said in a statement yesterday. The Kenyan officers on Tuesday were on their way to rescue Haitian police stuck in a ditch “suspected to have been deliberately dug by gangs,” the statement said, adding that “specialized teams have been deployed” to search for the missing officer. Local media outlets in Haiti reported that the officer had been killed and videos of a lifeless man clothed in Kenyan uniform were shared on social media. Gang violence has left
US Vice President J.D. Vance on Friday accused Denmark of not having done enough to protect Greenland, when he visited the strategically placed and resource-rich Danish territory coveted by US President Donald Trump. Vance made his comment during a trip to the Pituffik Space Base in northwestern Greenland, a visit viewed by Copenhagen and Nuuk as a provocation. “Our message to Denmark is very simple: You have not done a good job by the people of Greenland,” Vance told a news conference. “You have under-invested in the people of Greenland, and you have under-invested in the security architecture of this
RSS